findmyKOL
Clinical trialNCT05942911TerminatedPhase 2Interventional

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

SponsorIncannex Healthcare LtdEnrollment20Rheumatoid Arthritis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Paratus Clinical (woden Dermatology)

    Phillip, Australian Capital Territory, Australia

  • Genesis Research Services

    Broadmeadow, New South Wales, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Novatrials

    Kotara, New South Wales, Australia

  • Emeritus Research

    Sydney, New South Wales, Australia

  • Coast Joint Care

    Maroochydore, Queensland, Australia

  • Austrials Westside (taringa)

    Taringa, Queensland, Australia

  • Austrials Wellers Hill

    Wellers Hill, Queensland, Australia

  • Emeritus Research Melbourne

    Camberwell, Victoria, Australia

  • Captain Sterling Medical Centre

    Nedlands, Western Australia, Australia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Nov 2023
Primary completion
28 Oct 2024
Completion
28 Oct 2025
Last update posted
27 Mar 2026
Registered enrollment
20
Registry id
NCT05942911

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.